Stelac Advisory Services LLC Repligen Corp Transaction History

Stelac Advisory Services LLC

  • $239 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$162.42 - $220.56 $23,226 - $31,540
143 Added 6.95%
2,201 $372,000
Q2 2022

Aug 10, 2022
BUY
$140.68 - $188.02 $198,218 - $264,920
1,409 Added 217.1%
2,058 $334,000
Q1 2022

May 10, 2022
SELL
$161.19 - $257.96 $159,900 - $255,896
-992 Reduced 60.45%
649 $122,000
Q4 2021

Feb 14, 2022
BUY
$247.59 - $304.47 $151,277 - $186,031
611 Added 59.32%
1,641 $435,000
Q3 2021

Nov 15, 2021
BUY
$194.77 - $324.21 $200,613 - $333,936
1,030 New
1,030 $298,000

Others Institutions Holding RGEN

# of Institutions
476
Shares Held
54.5M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.87B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Stelac Advisory Services LLC Portfolio

Follow Stelac Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stelac Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stelac Advisory Services LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email